A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session0d870b955ac440b6c67bab2e50dc820d70d5f3fc): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Beyond the Pill Market Research Report 2024

img

Global Beyond the Pill Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Beyond the Pill Market Research Report 2024

Beyond the pill refers to a shift in the pharmaceutical industry towards providing holistic healthcare services and products that go beyond traditional drug-based treatments. The term "beyond the pill" emphasizes the need for pharmaceutical companies to provide additional support and services to patients beyond simply prescribing medications.Beyond the pill offerings can include a wide range of products and services, such as patient education programs, digital health technologies, medical devices, and patient monitoring services. The goal of these offerings is to improve patient outcomes and satisfaction while also providing additional revenue streams for pharmaceutical companies.
According to MRAResearch’s new survey, global Beyond the Pill market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Beyond the Pill market research.
The beyond the pill market has seen significant growth in recent years, driven by factors such as the increasing importance of patient-centered care, the rise of digital health technologies, and the growing demand for value-based healthcare. Key players in the beyond the pill market include major pharmaceutical companies such as Pfizer, Roche, Novartis, and Sanofi, as well as a number of smaller startups and technology companies.
The beyond the pill market is expected to continue to grow as more pharmaceutical companies recognize the importance of providing holistic healthcare solutions and as patients continue to demand more personalized and integrated care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Beyond the Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis AG
Sanofi S.A
Novo Nordisk A/S
Eli Lilly and Company
F. Hoffmann-La Roche AG (Flatiron Health)
Otsuka Pharmaceuticals Co., Ltd
Amgen, Inc.
AstraZeneca Plc
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Segment by Type
Services
Monitoring
Assistance

Segment by Application


Diabetes
Oncology
Cardiovascular Diseases
Asthma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Beyond the Pill report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Beyond the Pill Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Services
1.2.3 Monitoring
1.2.4 Assistance
1.3 Market by Application
1.3.1 Global Beyond the Pill Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diabetes
1.3.3 Oncology
1.3.4 Cardiovascular Diseases
1.3.5 Asthma
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Beyond the Pill Market Perspective (2018-2033)
2.2 Beyond the Pill Growth Trends by Region
2.2.1 Global Beyond the Pill Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Beyond the Pill Historic Market Size by Region (2018-2023)
2.2.3 Beyond the Pill Forecasted Market Size by Region (2024-2033)
2.3 Beyond the Pill Market Dynamics
2.3.1 Beyond the Pill Industry Trends
2.3.2 Beyond the Pill Market Drivers
2.3.3 Beyond the Pill Market Challenges
2.3.4 Beyond the Pill Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Beyond the Pill Players by Revenue
3.1.1 Global Top Beyond the Pill Players by Revenue (2018-2023)
3.1.2 Global Beyond the Pill Revenue Market Share by Players (2018-2023)
3.2 Global Beyond the Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Beyond the Pill Revenue
3.4 Global Beyond the Pill Market Concentration Ratio
3.4.1 Global Beyond the Pill Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Beyond the Pill Revenue in 2022
3.5 Beyond the Pill Key Players Head office and Area Served
3.6 Key Players Beyond the Pill Product Solution and Service
3.7 Date of Enter into Beyond the Pill Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Beyond the Pill Breakdown Data by Type
4.1 Global Beyond the Pill Historic Market Size by Type (2018-2023)
4.2 Global Beyond the Pill Forecasted Market Size by Type (2024-2033)
5 Beyond the Pill Breakdown Data by Application
5.1 Global Beyond the Pill Historic Market Size by Application (2018-2023)
5.2 Global Beyond the Pill Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Beyond the Pill Market Size (2018-2033)
6.2 North America Beyond the Pill Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Beyond the Pill Market Size by Country (2018-2023)
6.4 North America Beyond the Pill Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Beyond the Pill Market Size (2018-2033)
7.2 Europe Beyond the Pill Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Beyond the Pill Market Size by Country (2018-2023)
7.4 Europe Beyond the Pill Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Beyond the Pill Market Size (2018-2033)
8.2 Asia-Pacific Beyond the Pill Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Beyond the Pill Market Size by Region (2018-2023)
8.4 Asia-Pacific Beyond the Pill Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Beyond the Pill Market Size (2018-2033)
9.2 Latin America Beyond the Pill Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Beyond the Pill Market Size by Country (2018-2023)
9.4 Latin America Beyond the Pill Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Beyond the Pill Market Size (2018-2033)
10.2 Middle East & Africa Beyond the Pill Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Beyond the Pill Market Size by Country (2018-2023)
10.4 Middle East & Africa Beyond the Pill Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Beyond the Pill Introduction
11.1.4 Novartis AG Revenue in Beyond the Pill Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Sanofi S.A
11.2.1 Sanofi S.A Company Detail
11.2.2 Sanofi S.A Business Overview
11.2.3 Sanofi S.A Beyond the Pill Introduction
11.2.4 Sanofi S.A Revenue in Beyond the Pill Business (2018-2023)
11.2.5 Sanofi S.A Recent Development
11.3 Novo Nordisk A/S
11.3.1 Novo Nordisk A/S Company Detail
11.3.2 Novo Nordisk A/S Business Overview
11.3.3 Novo Nordisk A/S Beyond the Pill Introduction
11.3.4 Novo Nordisk A/S Revenue in Beyond the Pill Business (2018-2023)
11.3.5 Novo Nordisk A/S Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Detail
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Beyond the Pill Introduction
11.4.4 Eli Lilly and Company Revenue in Beyond the Pill Business (2018-2023)
11.4.5 Eli Lilly and Company Recent Development
11.5 F. Hoffmann-La Roche AG (Flatiron Health)
11.5.1 F. Hoffmann-La Roche AG (Flatiron Health) Company Detail
11.5.2 F. Hoffmann-La Roche AG (Flatiron Health) Business Overview
11.5.3 F. Hoffmann-La Roche AG (Flatiron Health) Beyond the Pill Introduction
11.5.4 F. Hoffmann-La Roche AG (Flatiron Health) Revenue in Beyond the Pill Business (2018-2023)
11.5.5 F. Hoffmann-La Roche AG (Flatiron Health) Recent Development
11.6 Otsuka Pharmaceuticals Co., Ltd
11.6.1 Otsuka Pharmaceuticals Co., Ltd Company Detail
11.6.2 Otsuka Pharmaceuticals Co., Ltd Business Overview
11.6.3 Otsuka Pharmaceuticals Co., Ltd Beyond the Pill Introduction
11.6.4 Otsuka Pharmaceuticals Co., Ltd Revenue in Beyond the Pill Business (2018-2023)
11.6.5 Otsuka Pharmaceuticals Co., Ltd Recent Development
11.7 Amgen, Inc.
11.7.1 Amgen, Inc. Company Detail
11.7.2 Amgen, Inc. Business Overview
11.7.3 Amgen, Inc. Beyond the Pill Introduction
11.7.4 Amgen, Inc. Revenue in Beyond the Pill Business (2018-2023)
11.7.5 Amgen, Inc. Recent Development
11.8 AstraZeneca Plc
11.8.1 AstraZeneca Plc Company Detail
11.8.2 AstraZeneca Plc Business Overview
11.8.3 AstraZeneca Plc Beyond the Pill Introduction
11.8.4 AstraZeneca Plc Revenue in Beyond the Pill Business (2018-2023)
11.8.5 AstraZeneca Plc Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Beyond the Pill Introduction
11.9.4 Johnson & Johnson Revenue in Beyond the Pill Business (2018-2023)
11.9.5 Johnson & Johnson Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Beyond the Pill Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Beyond the Pill Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Beyond the Pill Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Services
Table 3. Key Players of Monitoring
Table 4. Key Players of Assistance
Table 5. Global Beyond the Pill Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Beyond the Pill Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Beyond the Pill Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Beyond the Pill Market Share by Region (2018-2023)
Table 9. Global Beyond the Pill Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Beyond the Pill Market Share by Region (2024-2033)
Table 11. Beyond the Pill Market Trends
Table 12. Beyond the Pill Market Drivers
Table 13. Beyond the Pill Market Challenges
Table 14. Beyond the Pill Market Restraints
Table 15. Global Beyond the Pill Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Beyond the Pill Market Share by Players (2018-2023)
Table 17. Global Top Beyond the Pill Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beyond the Pill as of 2022)
Table 18. Ranking of Global Top Beyond the Pill Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Beyond the Pill Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Beyond the Pill Product Solution and Service
Table 22. Date of Enter into Beyond the Pill Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Beyond the Pill Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Beyond the Pill Revenue Market Share by Type (2018-2023)
Table 26. Global Beyond the Pill Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Beyond the Pill Revenue Market Share by Type (2024-2033)
Table 28. Global Beyond the Pill Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Beyond the Pill Revenue Market Share by Application (2018-2023)
Table 30. Global Beyond the Pill Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Beyond the Pill Revenue Market Share by Application (2024-2033)
Table 32. North America Beyond the Pill Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Beyond the Pill Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Beyond the Pill Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Beyond the Pill Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Beyond the Pill Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Beyond the Pill Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Beyond the Pill Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Beyond the Pill Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Beyond the Pill Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Beyond the Pill Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Beyond the Pill Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Beyond the Pill Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Beyond the Pill Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Beyond the Pill Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Beyond the Pill Market Size by Country (2024-2033) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Beyond the Pill Product
Table 50. Novartis AG Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Sanofi S.A Company Detail
Table 53. Sanofi S.A Business Overview
Table 54. Sanofi S.A Beyond the Pill Product
Table 55. Sanofi S.A Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 56. Sanofi S.A Recent Development
Table 57. Novo Nordisk A/S Company Detail
Table 58. Novo Nordisk A/S Business Overview
Table 59. Novo Nordisk A/S Beyond the Pill Product
Table 60. Novo Nordisk A/S Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 61. Novo Nordisk A/S Recent Development
Table 62. Eli Lilly and Company Company Detail
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Beyond the Pill Product
Table 65. Eli Lilly and Company Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. F. Hoffmann-La Roche AG (Flatiron Health) Company Detail
Table 68. F. Hoffmann-La Roche AG (Flatiron Health) Business Overview
Table 69. F. Hoffmann-La Roche AG (Flatiron Health) Beyond the Pill Product
Table 70. F. Hoffmann-La Roche AG (Flatiron Health) Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 71. F. Hoffmann-La Roche AG (Flatiron Health) Recent Development
Table 72. Otsuka Pharmaceuticals Co., Ltd Company Detail
Table 73. Otsuka Pharmaceuticals Co., Ltd Business Overview
Table 74. Otsuka Pharmaceuticals Co., Ltd Beyond the Pill Product
Table 75. Otsuka Pharmaceuticals Co., Ltd Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 76. Otsuka Pharmaceuticals Co., Ltd Recent Development
Table 77. Amgen, Inc. Company Detail
Table 78. Amgen, Inc. Business Overview
Table 79. Amgen, Inc. Beyond the Pill Product
Table 80. Amgen, Inc. Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 81. Amgen, Inc. Recent Development
Table 82. AstraZeneca Plc Company Detail
Table 83. AstraZeneca Plc Business Overview
Table 84. AstraZeneca Plc Beyond the Pill Product
Table 85. AstraZeneca Plc Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 86. AstraZeneca Plc Recent Development
Table 87. Johnson & Johnson Company Detail
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Beyond the Pill Product
Table 90. Johnson & Johnson Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Teva Pharmaceutical Industries Ltd. Company Detail
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Beyond the Pill Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Beyond the Pill Business (2018-2023) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Beyond the Pill Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Beyond the Pill Market Share by Type: 2022 VS 2033
Figure 3. Services Features
Figure 4. Monitoring Features
Figure 5. Assistance Features
Figure 6. Global Beyond the Pill Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Beyond the Pill Market Share by Application: 2022 VS 2033
Figure 8. Diabetes Case Studies
Figure 9. Oncology Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Asthma Case Studies
Figure 12. Other Case Studies
Figure 13. Beyond the Pill Report Years Considered
Figure 14. Global Beyond the Pill Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Beyond the Pill Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Beyond the Pill Market Share by Region: 2022 VS 2033
Figure 17. Global Beyond the Pill Market Share by Players in 2022
Figure 18. Global Top Beyond the Pill Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beyond the Pill as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Beyond the Pill Revenue in 2022
Figure 20. North America Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Beyond the Pill Market Share by Country (2018-2033)
Figure 22. United States Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Beyond the Pill Market Share by Country (2018-2033)
Figure 26. Germany Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Beyond the Pill Market Share by Region (2018-2033)
Figure 34. China Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Beyond the Pill Market Share by Country (2018-2033)
Figure 42. Mexico Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Beyond the Pill Market Share by Country (2018-2033)
Figure 46. Turkey Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Beyond the Pill Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 49. Sanofi S.A Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 50. Novo Nordisk A/S Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 51. Eli Lilly and Company Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 52. F. Hoffmann-La Roche AG (Flatiron Health) Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 53. Otsuka Pharmaceuticals Co., Ltd Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 54. Amgen, Inc. Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 55. AstraZeneca Plc Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 56. Johnson & Johnson Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Beyond the Pill Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries